Impotence therapy and cancer of the prostate.
Prostate cancer developed in two male patients being treated with fluoxymesterone for erectile impotence. It is suggested that the current increased interest in and therapy for sexual dysfunction be accompanied by an awareness of a possible causal relationship between exogenous androgens and prostrate cancer.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D000368:Aged; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004334:Drug Administration Schedule; D007172:Erectile Dysfunction / Q000188:drug therapy*; D005474:Fluoxymesterone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000150:complications; D011471:Prostatic Neoplasms / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D004054:Diethylstilbestrol; D005474:Fluoxymesterone